Shionogi has seen as-yet unreleased Phase 2 data from teeny biotech Tetra which is focused on Alz and Fragile X Syndrome -- and has bought them. For 500 million.

https://endpts.com/phii-alzheimers-data-loomi...n-biotech/

There are currently 58.66 million shares outstanding of AVXL. AVXL is further along than Tetra. Hmmmmm